Form 4 Tracker
Andrew Reardon

CLO & Secretary · 10 filings · Latest: Oct 2, 2026

LIGAND PHARMACEUTICALS INC
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
LGND
Andrew ReardonCLO & SecretaryOct 2, 2026
Sale
$304.075,000$1.5M31,854
LGND
Andrew ReardonCLO & SecretaryOct 2, 2026
Option Exercise
$52.27340$17.8K36,854
LGND
Andrew ReardonCLO & SecretarySep 3, 2026
Sale
$286.095,000$1.4M36,514
LGND
ANDREW REARDON—Sep 3, 2026
Proposed Sale
$286.9215,000$4.3M—
LGND
Andrew ReardonCLO & SecretaryAug 3, 2026
Sale
$288.995,000$1.4M41,514
LGND
Andrew ReardonCLO & SecretaryAug 3, 2026
Option Exercise
$52.275,000$261.4K46,514
LGND
Andrew ReardonCLO & SecretaryJul 1, 2026
Sale
$313.285,000$1.6M41,514
LGND
Andrew ReardonCLO & SecretaryJul 1, 2026
Option Exercise
$52.275,000$261.4K46,514
LGND
ANDREW REARDON—Jul 1, 2026
Proposed Sale
$316.0910,000$3.2M—
LGND
Andrew ReardonCLO & SecretaryJun 1, 2026
Sale
$227.065,000$1.1M41,382
LGND
Andrew ReardonCLO & SecretaryJun 1, 2026
Option Exercise
$52.275,000$261.4K46,382
LGND
Andrew ReardonCLO & SecretaryMay 1, 2026
Sale
$231.315,000$1.2M41,382
LGND
Andrew ReardonCLO & SecretaryMay 1, 2026
Option Exercise
$52.275,000$261.4K46,382
LGND
Andrew ReardonCLO & SecretaryApr 1, 2026
Sale
$201.245,000$1.0M41,382
LGND
Andrew ReardonCLO & SecretaryApr 1, 2026
Option Exercise
$52.275,000$261.4K46,382
LGND
Andrew ReardonCLO & SecretaryMar 4, 2026
Sale
$206.355,000$1.0M36,869
LGND
Andrew ReardonCLO & SecretaryMar 4, 2026
Option Exercise
$52.275,000$261.4K41,869
LGND
ANDREW REARDON—Mar 4, 2026
Proposed Sale
$204.2420,000$4.1M—
LGND
ANDREW THOMAS REARDON—Jun 23, 2025
Proposed Sale
$114.08500$57.0K—
LGND
ANDREW THOMAS REARDON—Jun 10, 2025
Proposed Sale
$114.54500$57.3K—

Page 1 of 2

Next →